Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.860
+0.230 (6.34%)
At close: May 20, 2026
Market Cap386.04M +289.1%
Revenue (ttm)83.23M +153.6%
Net Income-2.59M
EPS-0.03
Shares Out100.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume98,317
Average Volume71,774
Open3.620
Previous Close3.630
Day's Range3.620 - 4.000
52-Week Range1.410 - 4.000
Beta0.52
RSI68.28
Earnings DateMay 13, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography... [Read more]

Sector Healthcare
Founded 2006
Employees 31
Stock Exchange Nordic Growth Market
Ticker Symbol BIOWKS
Full Company Profile

Financial Performance

In 2025, Bio-Works Technologies AB's revenue was 62.50 million, an increase of 105.02% compared to the previous year's 30.49 million. Losses were -15.25 million, -59.19% less than in 2024.

Financial Statements